Optimizing PCI Outcomes, Evolving Paradigms Covered at ACC
March 5, 2010 – Experts will lead an evening symposium during ACC 2010 that will cover the latest clinical and experimental breakthroughs in the percutaneous treatment of coronary artery disease. Those attending will be exposed to the latest clinical trial data on current and second-generation drug-eluting stent therapies.
The event is from 5–9:10 p.m. Saturday, March 13 at the Omni Hotel, 100 CNN Center, Atlanta.
The session includes both didactic and case-based presentations. Attendees will be exposed to the latest clinical and evidence-based medicine options to optimize patient outcomes in the treatment of coronary artery disease.
The program is sponsored by the Cardiovascular Research Foundation (CRF). This event is not part of the official ACC Annual Scientific Session or the i2 Summit.
For more information: www.pcioutcomes.com/register.html